Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
Patients on GLP-1s: Drugs Aren’t a ‘Magic Bullet’
Despite the common perception that GLP-1 use is an easy way out for weight loss, the reality is…
WHO Guidance, GLP-1 Price Curbs Unlikely to Change Practice
A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce…
Does Intermittent Fasting Improve Cardiometabolic Health?
A new study calls into question the effectiveness of time-restricted eating (TRE) in producing measurable improvements in metabolic…